Evidence map›Paper›PMID 40727621›Full record

ArticleDigital health

Mapping the landscape of machine learning in chronic disease management: A comprehensive bibliometric study.

Shiying Shen, Wenhao Qi, Sixie Li, Jianwen Zeng, Xin Liu, Xiaohong Zhu, Chaoqun Dong, Bin Wang, Qian Xu, Shihua Cao

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shiying ShenSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0009-0006-0817-0719
Wenhao QiSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0009-0001-8409-8134
Sixie LiSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0009-0006-7458-9761
Jianwen ZengSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0009-0000-8324-5545
Xin LiuSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0009-0002-2738-7674
Xiaohong ZhuSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0009-0009-6060-8134
Chaoqun DongSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0009-0002-2615-0931
Bin WangSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0009-0006-3441-9709
Qian XuSchool of Public Health, Angeles University Foundation, Angeles, Philippines.ORCID https://orcid.org/0009-0004-8722-6877
Shihua CaoSchool of Nursing, Hangzhou Normal University, Hangzhou, China.ORCID https://orcid.org/0000-0002-9391-2345

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to reveal global advancements and trends in machine learning (ML) for chronic disease management through a comprehensive bibliometric analysis, identifying research priorities to guide deeper exploration in the future. Methods: Relevant documents on ML and chronic disease management were retrieved from the core Web of Science database. Visual analyses of publication volume, research institutions, and countries were conducted using CiteSpace, VOSviewer, RStudio, and other software. An expert panel further analyzed the scale, trends, and potential connections between various ML algorithms and chronic diseases. Results: A total of 1,242 documents were included in this study. The findings indicate a continuous rise in studies on ML in chronic disease management, with the United States (n = 303, 23.5%) and China (n = 259, 20.1%) as primary research contributors. Logistic regression (n = 459) remains the most widely used algorithm, while neural networks (n = 183) show promising potential. Research hotspots are concentrated in diabetes and cardiovascular disease, focusing mainly on risk prediction, disease diagnosis, and personalized treatment. Conclusion: ML is rapidly integrating into personalized medicine, real-time monitoring, and multimodal data fusion. However, challenges such as limited collaboration, weak model generalization, and data privacy persist. Future efforts should prioritize algorithm optimization and multisource data integration to advance clinical applications.

Indexed as

artificial intelligencebibliometricschronic diseasedata visualizationdisease managementMachine learning

Identifiers

PMID40727621
PMCPMC12301648

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.